Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT)

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2357

Title:	Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT)
Authors:	Dijkmans, B Sieper, J DeWoody, K Williamson, R Braun, J VAN DER HEIJDE, Desiree GEUSENS, Piet
Issue Date:	2004
Publisher:	B M J PUBLISHING GROUP
Source:	ANNALS OF THE RHEUMATIC DISEASES, 63. p. 403-403
Notes:	Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands. Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Rheumatol, Amsterdam, Netherlands. Limburgs Univ Ctr, Diepenbeek, Belgium. Free Univ Berlin, Klinikum Benjamin Franklin, Abt Rheumatol, D-12200 Berlin, Germany. Centocor Inc, Biostat, Malvern, PA 19355 USA. Centocor Inc, Clin Res & Dev, Malvern, PA 19355 USA. Rheumazentrum Ruhrgebiet, Herne, Germany.
Document URI:	http://hdl.handle.net/1942/2357
ISSN:	0003-4967
e-ISSN:	1468-2060
ISI #:	000224551501359
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

1

checked on Apr 16, 2024

26

checked on May 30, 2023

Check